tradingkey.logo

Neuropace Inc

NPCE

8.930USD

-0.060-0.67%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
292.47MCap. mercado
PérdidaP/E TTM

Neuropace Inc

8.930

-0.060-0.67%
Más Datos de Neuropace Inc Compañía
NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.
Información de la empresa
Símbolo de cotizaciónNPCE
Nombre de la empresaNeuropace Inc
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoMr. Joel D. Becker
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección455 N. Bernardo Avenue
CiudadMOUNTAIN VIEW
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal94043
Teléfono16502372700
Sitio Webhttps://www.neuropace.com/
Símbolo de cotizaciónNPCE
Fecha de salida a bolsaApr 22, 2021
Director ejecutivoMr. Joel D. Becker
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
Desglose de ingresos
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
22.52M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 4 de jun
Actualizado: mié., 4 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
Tipos de accionistas
Accionistas
Proporción
Private Equity
23.90%
Hedge Fund
20.38%
Investment Advisor/Hedge Fund
19.42%
Investment Advisor
13.63%
Research Firm
8.48%
Individual Investor
2.75%
Pension Fund
0.40%
Bank and Trust
0.04%
Insurance Company
0.02%
Other
10.96%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
183
29.20M
89.03%
-971.50K
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
2023Q2
106
24.30M
96.22%
-2.15M
2023Q1
107
24.47M
97.75%
-1.64M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Accelmed Growth Partners Management Ltd
4.43M
13.52%
--
--
Apr 09, 2025
OrbiMed Advisors, LLC
3.41M
10.39%
--
--
Mar 31, 2025
Soleus Capital Management, L.P.
2.61M
7.95%
+175.00K
+7.19%
Mar 31, 2025
Morgan Stanley & Co. LLC
2.52M
7.7%
+38.83K
+1.56%
Mar 31, 2025
Polar Capital LLP
2.50M
7.62%
-472.00K
-15.88%
Apr 09, 2025
First Light Asset Management, LLC
1.58M
4.83%
+1.58M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.20M
3.65%
+140.78K
+13.32%
Mar 31, 2025
Armistice Capital LLC
1.15M
3.52%
+561.00K
+94.67%
Mar 31, 2025
Kent Lake PR LLC
950.00K
2.9%
-532.55K
-35.92%
Mar 31, 2025
DWS Investments UK Limited
923.92K
2.82%
+511.66K
+124.11%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Neuroscience and Healthcare ETF
0.63%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Principal U.S. Small-Cap ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver más
iShares Neuroscience and Healthcare ETF
Proporción0.63%
iShares Micro-Cap ETF
Proporción0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 Growth ETF
Proporción0.02%
Principal U.S. Small-Cap ETF
Proporción0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI